Natera (NTRA) Non-Current Deferred Tax Liability (2025 - 2026)
Natera's (NTRA) quarterly Non-Current Deferred Tax Liability came in at $701000.0 in Q1 2026, little changed on a QoQ basis from $701000.0 in Q4 2025.
Natera (NTRA) Non-Current Deferred Tax Liability (2025 - 2026) Analysis & Trends
Natera (NTRA) has 2 years of Non-Current Deferred Tax Liability data on file, last reported at $701000.0 in Q1 2026.
- Quarterly Non-Current Deferred Tax Liability changed N/A year-over-year to $701000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $701000.0 (changed N/A YoY) and the FY2025 annual result came in at $701000.0, changed N/A from the prior year.
- Non-Current Deferred Tax Liability held at $701000.0 in Q1 2026, from $701000.0 in the prior quarter.
- In the past five years, Non-Current Deferred Tax Liability ranged from a high of $701000.0 in Q4 2025 to a low of $701000.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 212.62 Bn | 208.56 Bn | 8.34 Bn |
| 2 | Danaher | 139.22 Bn | 134.87 Bn | 3.61 Bn |
| 3 | Idexx Laboratories | 46.07 Bn | 45.88 Bn | 779.09 Mn |
| 4 | Agilent Technologies | 39.35 Bn | 37.54 Bn | 990.00 Mn |
| 5 | Iqvia Holdings | 38.18 Bn | 36.10 Bn | 1.44 Bn |
| 6 | Natera | 37.68 Bn | 36.58 Bn | 696.04 Mn |
| 7 | Illumina | 28.60 Bn | 27.43 Bn | 770.00 Mn |
| 8 | Mettler Toledo International | 28.37 Bn | 28.32 Bn | 650.22 Mn |
| 9 | Quest Diagnostics | 26.30 Bn | 25.67 Bn | 1.03 Bn |
| 10 | Labcorp Holdings | 25.82 Bn | 24.84 Bn | 1.01 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 701,000.00 |
| Mar 31, 2026 | 701,000.00 |
| Dec 31, 2025 | 701,000.00 |
| Dec 31, 2025 | 701,000.00 |